Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05391217 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors

Study acronym: STRIDE
StatusUnknown
PhaseNot specified
Started2023-02-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 27, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Recruiting → Unknown
2024-08-23
Active, Not Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusActive, Not Recruiting→Unknown
Primary completion date2024-06-01→2025-07-01
Completion date2024-06-01→2025-07-01
Start date2022-02-01→2023-02-01
Study sitesdetails revised at 1 of 1 site
2022-05-24
Original filing
Prospective observational feasibility study to evaluate the role of wearable activity monitors to determine the feasibility and acceptability of remote monitoring using wearable technology and PROs to monitor fatigue and physical function in transgender cancer patients and survivors.
Trial Details
NCT Number NCT05391217
Lead Sponsor Cedars-Sinai Medical Center
Conditions Neoplasms, Chronic Disease
Enrollment 20 participants
Start Date 2023-02-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-27